At 0 2 0 2 O
the 3 6 3 6 O
time 7 11 7 11 O
of 12 14 12 14 O
surgery 15 22 15 22 B-treatment
, 22 23 22 23 O
operative 24 33 24 33 O
assessment 34 44 34 44 O
and 45 48 45 48 O
frozen 49 55 49 55 O
section 56 63 56 63 O
diagnosis 64 73 64 73 O
of 74 76 74 76 O
one 77 80 77 80 O
of 81 83 81 83 O
the 84 87 84 87 O
following 88 97 88 97 O

Metastatic 0 10 98 108 B-cancer
mesothelioma 11 23 109 121 I-cancer
or 24 26 122 124 O
sarcoma 27 34 125 132 B-cancer
confined 35 43 133 141 O
to 44 46 142 144 O
the 47 50 145 148 O
abdomen 51 58 149 156 O

Patients 0 8 157 165 O
are 9 12 166 169 O
at 13 15 170 172 O
least 16 21 173 178 O
18 22 24 179 181 B-lower_bound
years 25 30 182 187 I-lower_bound
of 31 33 188 190 O
age 34 37 191 194 B-age
, 37 38 194 195 O
and 39 42 196 199 O
under 43 48 200 205 O
75 49 51 206 208 B-upper_bound
years 52 57 209 214 I-upper_bound
of 58 60 215 217 O
age 61 64 218 221 O

Patients 0 8 222 230 O
must 9 13 231 235 O
have 14 18 236 240 O
a 19 20 241 242 O
performance 21 32 243 254 B-clinical_variable
status 33 39 255 261 I-clinical_variable
of 40 42 262 264 O
0 43 44 265 266 B-lower_bound
, 44 45 266 267 O
1 46 47 268 269 O
, 47 48 269 270 O
or 49 51 271 273 O
2 52 53 274 275 B-upper_bound

Patients 0 8 276 284 O
of 9 11 285 287 O
childbearing 12 24 288 300 O
potential 25 34 301 310 O
must 35 39 311 315 O
have 40 44 316 320 O
a 45 46 321 322 O
negative 47 55 323 331 B-pregnancy
serum 56 61 332 337 I-pregnancy
pregnancy 62 71 338 347 I-pregnancy
test 72 76 348 352 O
prior 77 82 353 358 O
to 83 85 359 361 O
study 86 91 362 367 O
entry 92 97 368 373 O
and 98 101 374 377 O
be 102 104 378 380 O
practicing 105 115 381 391 O
an 116 118 392 394 O
effective 119 128 395 404 O
form 129 133 405 409 O
of 134 136 410 412 O
contraception 137 150 413 426 O

Patients 0 8 427 435 O
with 9 13 436 440 O
any 14 17 441 444 O
evidence 18 26 445 453 O
of 27 29 454 456 O
another 30 37 457 464 O
malignancy 38 48 465 475 B-cancer
within 49 55 476 482 O
the 56 59 483 486 O
last 60 64 487 491 B-upper_bound
five 65 69 492 496 I-upper_bound
years 70 75 497 502 I-upper_bound
( 76 77 503 504 O
except 77 83 504 510 O
non 84 87 511 514 B-cancer
- 87 88 514 515 I-cancer
melanoma 88 96 515 523 I-cancer
skin 97 101 524 528 I-cancer
cancer 102 108 529 535 I-cancer
) 108 109 535 536 O
Patients 110 118 537 545 O
with 119 123 546 550 O
a 124 125 551 552 O
known 126 131 553 558 O
sensitivity 132 143 559 570 O
to 144 146 571 573 O
cisplatin 147 156 574 583 B-allergy_name
, 156 157 583 584 O
Mitomycin 158 167 585 594 B-allergy_name
C 168 169 595 596 I-allergy_name
, 169 170 596 597 O
or 171 173 598 600 O
Adriamycin 174 184 601 611 B-allergy_name

Patients 0 8 612 620 O
with 9 13 621 625 O
known 14 19 626 631 O
extra 20 25 632 637 B-chronic_disease
- 25 26 637 638 I-chronic_disease
abdominal 26 35 638 647 I-chronic_disease
disease 36 43 648 655 O
, 43 44 655 656 O
or 45 47 657 659 O
unresected 48 58 660 670 O
bulky 59 64 671 676 O
abdominal 65 74 677 686 O
retroperitoneal 75 90 687 702 O
lymph 91 96 703 708 O
nodes 97 102 709 714 O

Patients 0 8 715 723 O
with 9 13 724 728 O
significant 14 25 729 740 O
co 26 28 741 743 B-chronic_disease
- 28 29 743 744 I-chronic_disease
morbid 29 35 744 750 I-chronic_disease
medical 36 43 751 758 I-chronic_disease
conditions 44 54 759 769 I-chronic_disease
that 55 59 770 774 O
would 60 65 775 780 O
prevent 66 73 781 788 O
the 74 77 789 792 O
patient 78 85 793 800 O
from 86 90 801 805 O
completing 91 101 806 816 O
treatment 102 111 817 826 B-treatment
on 112 114 827 829 O
this 115 119 830 834 O
protocol 120 128 835 843 O
, 128 129 843 844 O
per 130 133 845 848 O
Investigator 134 146 849 861 O
discretion 147 157 862 872 O

Presumptive 0 11 873 884 O
clinical 12 20 885 893 O
diagnosis 21 30 894 903 O
of 31 33 904 906 O
a 34 35 907 908 O
peritoneal 36 46 909 919 B-cancer
surface 47 54 920 927 I-cancer
cancer 55 61 928 934 I-cancer
( 62 63 935 936 I-cancer
PSC 63 66 936 939 I-cancer
) 66 67 939 940 I-cancer
prior 68 73 941 946 O
to 74 76 947 949 O
surgery 77 84 950 957 B-treatment
, 84 85 957 958 O
with 86 90 959 963 O
no 91 93 964 966 O
metastases 94 104 967 977 B-cancer
outside 105 112 978 985 O
of 113 115 986 988 O
the 116 119 989 992 O
abdomen 120 127 993 1000 O

Primary 0 7 1001 1008 B-cancer
ovarian 8 15 1009 1016 I-cancer
cancer 16 22 1017 1023 I-cancer
( 23 24 1024 1025 I-cancer
POC 24 27 1025 1028 I-cancer
) 27 28 1028 1029 I-cancer
with 29 33 1030 1034 O
Stage 34 39 1035 1040 O
IC 40 42 1041 1043 O
or 43 45 1044 1046 O
greater 46 53 1047 1054 O
stage 54 59 1055 1060 O
Recurrent 60 69 1061 1070 O
or 70 72 1071 1073 O
persistent 73 83 1074 1084 B-cancer
ovarian 84 91 1085 1092 I-cancer
cancer 92 98 1093 1099 I-cancer
( 99 100 1100 1101 I-cancer
ROC 100 103 1101 1104 I-cancer
) 103 104 1104 1105 I-cancer
Ovarian 105 112 1106 1113 B-cancer
cancer 113 119 1114 1120 I-cancer
patients 120 128 1121 1129 O
who 129 132 1130 1133 O
desire 133 139 1134 1140 O
Consolidation 140 153 1141 1154 B-treatment
Chemotherapy 154 166 1155 1167 I-treatment
( 167 168 1168 1169 I-treatment
CC 168 170 1169 1171 I-treatment
) 170 171 1171 1172 I-treatment

Recurrent 0 9 1173 1182 B-cancer
or 10 12 1183 1185 I-cancer
primary 13 20 1186 1193 I-cancer
gastrointestinal 21 37 1194 1210 I-cancer
cancer 38 44 1211 1217 I-cancer
, 44 45 1217 1218 O
with 46 50 1219 1223 O
regional 51 59 1224 1232 O
spread 60 66 1233 1239 O
confined 67 75 1240 1248 O
to 76 78 1249 1251 O
the 79 82 1252 1255 O
peritoneal 83 93 1256 1266 O
cavity 94 100 1267 1273 O

These 0 5 1274 1279 O
patients 6 14 1280 1288 O
would 15 20 1289 1294 O
ordinarily 21 31 1295 1305 O
choose 32 38 1306 1312 O
to 39 41 1313 1315 O
have 42 46 1316 1320 O
12 47 49 1321 1323 B-upper_bound
cycles 50 56 1324 1330 I-upper_bound
of 57 59 1331 1333 O
Taxol 60 65 1334 1339 B-treatment
given 66 71 1340 1345 O
after 72 77 1346 1351 B-treatment
standard 78 86 1352 1360 I-treatment
first 87 92 1361 1366 I-treatment
- 92 93 1366 1367 I-treatment
line 93 97 1367 1371 I-treatment
surgery 98 105 1372 1379 I-treatment
and 106 109 1380 1383 O
chemotherapy 110 122 1384 1396 B-treatment
, 122 123 1396 1397 O
and 124 127 1398 1401 O
instead 128 135 1402 1409 O
choose 136 142 1410 1416 O
one 143 146 1417 1420 O
course 147 153 1421 1427 O
of 154 156 1428 1430 O
IPHC 157 161 1431 1435 B-treatment
as 162 164 1436 1438 O
their 165 170 1439 1444 O
CC 171 173 1445 1447 O

Uterine 0 7 1448 1455 O
malignancy 8 18 1456 1466 B-cancer
of 19 21 1467 1469 O
the 22 25 1470 1473 O
corpus 26 32 1474 1480 O
, 32 33 1480 1481 O
or 34 36 1482 1484 O
cervix 37 43 1485 1491 O
with 44 48 1492 1496 O
primary 49 56 1497 1504 B-chronic_disease
tumor 57 62 1505 1510 I-chronic_disease
Stage 63 68 1511 1516 B-lower_bound
IIIA 69 73 1517 1521 I-lower_bound
or 74 76 1522 1524 O
greater 77 84 1525 1532 O
, 84 85 1532 1533 O
or 86 88 1534 1536 O
recurrent 89 98 1537 1546 O
tumor 99 104 1547 1552 O
confined 105 113 1553 1561 O
to 114 116 1562 1564 O
the 117 120 1565 1568 O
abdomen 121 128 1569 1576 O

absolute 0 8 1577 1585 B-clinical_variable
neutrophil 9 19 1586 1596 I-clinical_variable
count 20 25 1597 1602 I-clinical_variable
more 26 30 1603 1607 O
than 31 35 1608 1612 O
or 36 38 1613 1615 O
equal 39 44 1616 1621 O
to 45 47 1622 1624 O
1500 48 52 1625 1629 B-lower_bound
and 53 56 1630 1633 O
platelet 57 65 1634 1642 B-clinical_variable
count 66 71 1643 1648 I-clinical_variable
more 72 76 1649 1653 O
than 77 81 1654 1658 O
or 82 84 1659 1661 O
equal 85 90 1662 1667 O
to 91 93 1668 1670 O
100,000 94 101 1671 1678 B-lower_bound
Renal 102 107 1679 1684 O
function 108 116 1685 1693 O
: 116 117 1693 1694 O
creatinine 118 128 1695 1705 B-clinical_variable
less 129 133 1706 1710 O
than 134 138 1711 1715 O
or 139 141 1716 1718 O
equal 142 147 1719 1724 O
to 148 150 1725 1727 O
1.5 151 154 1728 1731 B-upper_bound
mg 155 157 1732 1734 I-upper_bound
/ 157 158 1734 1735 I-upper_bound
dl 158 160 1735 1737 I-upper_bound
Hepatic 161 168 1738 1745 O
function 169 177 1746 1754 O
: 177 178 1754 1755 O
bilirubin 179 188 1756 1765 B-clinical_variable
less 189 193 1766 1770 O
than 194 198 1771 1775 O
or 199 201 1776 1778 O
equal 202 207 1779 1784 O
1.5times 208 216 1785 1793 B-upper_bound
upper 217 222 1794 1799 I-upper_bound
limit 223 228 1800 1805 I-upper_bound
of 229 231 1806 1808 I-upper_bound
normal 232 238 1809 1815 I-upper_bound
, 238 239 1815 1816 O
SGOT 240 244 1817 1821 B-clinical_variable
and 245 248 1822 1825 O
alkaline 249 257 1826 1834 B-clinical_variable
phosphatase 258 269 1835 1846 I-clinical_variable
less 270 274 1847 1851 O
than 275 279 1852 1856 O
or 280 282 1857 1859 O
equal 283 288 1860 1865 O
2.5 289 292 1866 1869 B-upper_bound
times 293 298 1870 1875 I-upper_bound
upper 299 304 1876 1881 I-upper_bound
limit 305 310 1882 1887 I-upper_bound
of 311 313 1888 1890 I-upper_bound
normal 314 320 1891 1897 I-upper_bound
range 321 326 1898 1903 O
Patients 327 335 1904 1912 O
must 336 340 1913 1917 O
have 341 345 1918 1922 O
signed 346 352 1923 1929 O
an 353 355 1930 1932 O
informed 356 364 1933 1941 O
consent 365 372 1942 1949 O

